Programme

An overview of the presentations is as follows (please click here to see preliminary programme):

Speaker	Presentation Title
Shankar Balasubramanian, Univ of Cambridge UK	Sequencing nucleic acids: from chemistry to life sciences and medicine
Clifford Barry, NIH, USA	Tuberculosis drug discovery: continuing to fail in good spirits
Michael Famulok, Univ of Bonn, Germany	Oligonucleotide-based tools for pharmacology and nano-engineering
Ben Feringa, Groningen Univ, The Netherlands	TBD
Carlos Garcia-Echeverria, Sanofi-Aventis, France	The future of kinase drug discovery - challenges and opportunities
Kim Janda, Scripps, USA	Vaccines as a new paradigm for the treatment of drug addiction
Harren Jhoti, Astex, UK	Fragment-based drug discovery: a decade of thinking small
Kostas Kostarelos, School of Pharmacy, UK	TBD
Richard Lerner, Scripps, USA	TBD
Roger Griffin, Newcastle Univ, UK	Modulation of DNA damage-response pathways in cancer therapy
Tom Muir, Princeton Univ, USA	The chemical biology of protein splicing
Shigeki Sasaki, Kyushu	Molecular design for selective recognition and reaction with RNA
Greg Verdine, Harvard Univ, USA	TBD
Herbert Waldmann, Max-Planck Institute Dortmund, Germany	Hunting the targets of natural product-inspired compounds
Robert M Williams, Colorado State Univ, USA	Total Synthesis as a Vehicle for Interrogating Biosynthetic and Biomechanistic Puzzles
Ben Davis, Oxford UK	Sugars and Proteins
Zhangjie Shi, Beijing	Direct Transformation of Unreactive ChemicalBonds

---

Preliminary Programme